Events and Related News
News
- April 24, 2013
THALLION ANNOUNCES 2013 FIRST QUARTER OPERATING RESULTS
- April 23, 2013
Thallion Delays Annual Meeting Date
- February 20, 2013
THALLION ANNOUNCES 2012 FOURTH QUARTER AND YEAR END OPERATING RESULTS
Thallion Pharmaceuticals Inc. (TSX: TLN) is a biotechnology company focused on developing a novel treatment for Shiga Toxin producing E coli infections.